Location | Brief description of research | Biospecimen types |
---|---|---|
IBRH3AU | ||
 Uganda and Botswana | HIV and HIV-tuberculosis (TB) | DNA |
 Addis Ababa, Ethiopia | Active TB disease | DNA |
 Kigali, Rwanda | Genocide exposure and post-traumatic stress | DNA |
 Kampala, Uganda | Trypanosomiasis and schistosomiasis | DNA and plasma |
I-HAB | ||
 Cotonou, Benin Republic | Tuberculosis | DNA |
 Accra, Ghana | Chronic kidney disease | DNA, plasma, serum, buffy coat, red cells, oral fluids, and urine |
 Accra, Ghana | Sickle cell | DNA, plasma, serum, buffy coat, red cells, and urine |
 Bamako, Mali | Hereditary neurological disorders | DNA |
 Abuja, Nigeria | Human papillomavirus | DNA |
 Abuja, Nigeria | Breast cancer | DNA |
 Ibadan, Nigeria | Glaucoma | DNA |
 Ibadan, Nigeria | Stroke | DNA, serum, plasma |
 Plateau, Nigeria | Breast milk affects and gut microbiome | DNA |
CLS | ||
 Cape Town, SA | Hearing impairment | DNA |
 Cape Town, SA | Maternal stress and offspring emotional and behavioral problems | DNA |
 Cape Town, SA | Pneumonia and wheezing illness | DNA |
 Cape Town, SA | Schizophrenia | DNA |
 Johannesburg, SA | Cardiovascular and metabolic health | DNA |
 Johannesburg, SA | Developmental disorders | DNA |
 Johannesburg, SA | Viral infections | DNA |